Companies: 10,795·Total market cap: $144.5T
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMONYSEHealthcare● Active
$472.80
$-9.23(-1.91%)
Market Cap$175.7B
P/E Ratio
52W High$643.99
52W Low$385.46
Overview

Thermo Fisher Scientific Inc. (TMO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

tmo · stock forecast · 42 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 42 Wall Street analysts in the past 3 months

SellBuy

Buy

42 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
37
Hold
5
Sell
0
Strong Sell
0
Total: 42 · Buy rate: 88.1%

12-Month Price Target

High

$685

Consensus

$617

+30.5% upside

Low

$490

Median: $629.5 · Last Close: $472.80

The Thermo Fisher Scientific Inc. (TMO) analyst consensus is Buy, based on ratings from 42 Wall Street analysts over the past 3 months. The average 12-month TMO price target is $617.20, representing +30.5% upside from the current price of $472.80.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $617 (30.5%)

Consensus Target

$617.20

30.5% upside

High Target

$685

44.9%

Low Target

$490

3.6%

Current Price

$472.80

as of today

Based on analyst price targets, the TMO stock price prediction for the next 12 months ranges from $490 to $685. The consensus TMO price forecast of $617.20 implies 30.5% upside from the current price of $472.80.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$485.512.69%

1-day model range: $483.75–$487.26. Peak: $487.26 (+2.69%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$430-9.1%
2028$404-14.5%
2029$389-17.7%
2030$379-19.8%
2031-21.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

21%8%71%
3Buy
1Neutral
10Sell
RSI (14)67.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · TMO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$480.98SELL
MA 10$473.73SELL
MA 20$461.89BUY
MA 50$479.63SELL
MA 100$508.70SELL
MA 200$526.58SELL
Current $TMO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$477.35SELL
EMA 10$473.92SELL
EMA 20$470.66BUY
EMA 50$479.68SELL
EMA 100$497.23SELL
EMA 200$508.55SELL
Current $TMO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HSBC2026-06-03
Downgrade ↓
BuyHold
Wells Fargo2026-05-08
Maintains
OverweightOverweight
Stifel2026-04-24
Maintains
BuyBuy
Baird2026-04-24
Maintains
OutperformOutperform
Barclays2026-04-14
Maintains
OverweightOverweight
Evercore ISI Group2026-04-06
Maintains
OutperformOutperform
Citigroup2026-01-30
Maintains
BuyBuy
Barclays2026-01-30
Maintains
OverweightOverweight
TD Cowen2026-01-30
Maintains
BuyBuy
Stifel2026-01-09
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Thermo Fisher Scientific Inc. (TMO) stock. Of the recent 371 rating actions, 14 were upgrades and 14 were downgrades. 42 analysts currently cover TMO.

Analyst Recommendation Trends

Buy ratings909
Hold ratings211
Sell ratings00

TMO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 9 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$47.8B

↓ 10.8% YoY

Revenue Next Year

$50.4B

↑ 5.4% YoY

EPS This Year

$24.86

EPS Next Year

$27.20

↑ 9.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TMO EPS of $24.86 for the current fiscal year, based on estimates from 14 analysts. The TMO revenue forecast is $47.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The TMO stock forecast is supported by two independent data sources: analyst consensus ratings from 42 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TMO price target is $617.20 (+30.5% upside), with an analyst consensus of Buy.

The TMO short-term stock prediction for tomorrow is $485.51 (+2.69%). The TMO stock price prediction for 2027 estimates an average of $430. The TMO stock prediction for 2030 projects a range of $364–$394.

Thermo Fisher Scientific Inc. trades on NYSE under the ticker TMO. The TMO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 88% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

TMO forecast · 8 questions

According to 42 Wall Street analysts, the average 12-month TMO price target is $617.20, with a high forecast of $685.00 and a low of $490.00. The median price target is shown in the chart above when available. This implies +30.5% potential upside from the current price of $472.80.

TMO price targetWhat is TMO price targetTMO analyst price targetTMO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.